Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Proton Therapy for Primary Breast Cancer.

Hug EB.

Breast Care (Basel). 2018 Jul;13(3):168-172. doi: 10.1159/000489893. Epub 2018 Jun 15. Review.

2.

Early Axial Growth Outcomes of Pediatric Patients Receiving Proton Craniospinal Irradiation.

De B, Cahlon O, Sine K, Mah D, Hug EB, Wolden SL.

J Pediatr Hematol Oncol. 2018 Nov;40(8):574-579. doi: 10.1097/MPH.0000000000001242.

3.

Dosimetric Comparison of Pencil-Beam Scanning and Photon-Based Radiation Therapy as a Boost in Carcinoma of Cervix.

Sharma MK, Hug EB, Bhushan M, Mah D, Maes D, Gairola M, Sharma SK, Yadav G, Pal M, Chauhan D, Dewan A, Kaur I, Tandon S, Mitra S.

Int J Part Ther. 2017 Fall;4(2):1-10. doi: 10.14338/IJPT-17-00009. Epub 2017 Dec 28.

4.

Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.

Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, DeSelm C, Fox JL, Mah D, Garg MK, Han-Chih Chang J, Lee NY.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):386-395. doi: 10.1016/j.ijrobp.2016.02.036. Epub 2016 Feb 17.

5.

Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?

Müller U, Kubik-Huch RA, Ares C, Hug EB, Löw R, Valavanis A, Ahlhelm FJ.

Acta Radiol. 2016 Feb;57(2):225-32. doi: 10.1177/0284185115574156. Epub 2015 Feb 25.

PMID:
25722460
6.

Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients.

Mast ME, Vredeveld EJ, Credoe HM, van Egmond J, Heijenbrok MW, Hug EB, Kalk P, van Kempen-Harteveld LM, Korevaar EW, van der Laan HP, Langendijk JA, Rozema HJ, Petoukhova AL, Schippers JM, Struikmans H, Maduro JH.

Breast Cancer Res Treat. 2014 Nov;148(1):33-9. doi: 10.1007/s10549-014-3149-6. Epub 2014 Oct 1.

7.

Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation.

Grosse N, Fontana AO, Hug EB, Lomax A, Coray A, Augsburger M, Paganetti H, Sartori AA, Pruschy M.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):175-81. doi: 10.1016/j.ijrobp.2013.09.041. Epub 2013 Nov 13.

PMID:
24239385
8.

Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms.

Schneider RA, Vitolo V, Albertini F, Koch T, Ares C, Lomax A, Goitein G, Hug EB.

Strahlenther Onkol. 2013 Dec;189(12):1020-5. doi: 10.1007/s00066-013-0432-0. Epub 2013 Sep 21.

PMID:
24052010
9.

Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at paul scherrer institute.

Rombi B, Ares C, Hug EB, Schneider R, Goitein G, Staab A, Albertini F, Bolsi A, Lomax AJ, Timmermann B.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):578-84. doi: 10.1016/j.ijrobp.2013.02.026. Epub 2013 Apr 12.

PMID:
23582853
10.

Dose to the developing dentition during therapeutic irradiation: organ at risk determination and clinical implications.

Thompson RF, Schneider RA, Albertini F, Lomax AJ, Ares C, Goitein G, Hug EB.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):108-13. doi: 10.1016/j.ijrobp.2012.11.041. Epub 2013 Jan 16.

PMID:
23332385
11.

Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.

Hartford AC, Paravati AJ, Spire WJ, Li Z, Jarvis LA, Fadul CE, Rhodes CH, Erkmen K, Friedman J, Gladstone DJ, Hug EB, Roberts DW, Simmons NE.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):650-5. doi: 10.1016/j.ijrobp.2012.05.027. Epub 2012 Jul 12.

PMID:
22795806
12.

Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery.

Jarvis LA, Simmons NE, Bellerive M, Erkmen K, Eskey CJ, Gladstone DJ, Hug EB, Roberts DW, Hartford AC.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):943-8. doi: 10.1016/j.ijrobp.2012.01.067. Epub 2012 Apr 9.

PMID:
22494581
13.

Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.

Pehlivan B, Ares C, Lomax AJ, Stadelmann O, Goitein G, Timmermann B, Schneider RA, Hug EB.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1432-40. doi: 10.1016/j.ijrobp.2011.10.042. Epub 2012 Feb 18.

PMID:
22349042
14.

Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.

Weber DC, Schneider R, Goitein G, Koch T, Ares C, Geismar JH, Schertler A, Bolsi A, Hug EB.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):865-71. doi: 10.1016/j.ijrobp.2011.08.027. Epub 2011 Dec 2.

PMID:
22138457
15.

In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes.

Fava G, Widesott L, Fellin F, Amichetti M, Viesi V, Lomax AJ, Lederer L, Hug EB, Fiorino C, Salvadori G, Di Muzio N, Schwarz M.

Radiother Oncol. 2012 Apr;103(1):18-24. doi: 10.1016/j.radonc.2011.11.004. Epub 2011 Nov 25.

PMID:
22119372
16.

Is it necessary to plan with safety margins for actively scanned proton therapy?

Albertini F, Hug EB, Lomax AJ.

Phys Med Biol. 2011 Jul 21;56(14):4399-413. doi: 10.1088/0031-9155/56/14/011. Epub 2011 Jun 27.

PMID:
21709340
17.

Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.

van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e313-9. doi: 10.1016/j.ijrobp.2011.05.005. Epub 2011 Jun 25.

PMID:
21708427
18.

Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.

van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1216-24. doi: 10.1016/j.ijrobp.2010.05.012. Epub 2010 Aug 21.

PMID:
20732761
19.

The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans.

Albertini F, Hug EB, Lomax AJ.

Phys Med Biol. 2010 May 21;55(10):2863-78. doi: 10.1088/0031-9155/55/10/005. Epub 2010 Apr 29.

PMID:
20427853
20.

Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.

Krayenbuehl J, Hartmann M, Lomax AJ, Kloeck S, Hug EB, Ciernik IF.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):628-34. doi: 10.1016/j.ijrobp.2009.11.006. Epub 2010 Apr 10.

PMID:
20385451
21.

Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?

Ares C, Khan S, Macartain AM, Heuberger J, Goitein G, Gruber G, Lutters G, Hug EB, Bodis S, Lomax AJ.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):685-97. doi: 10.1016/j.ijrobp.2009.02.062. Epub 2009 Jul 15.

PMID:
19615828
22.

Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.

Ares C, Hug EB, Lomax AJ, Bolsi A, Timmermann B, Rutz HP, Schuller JC, Pedroni E, Goitein G.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1111-8. doi: 10.1016/j.ijrobp.2008.12.055. Epub 2009 Apr 20.

PMID:
19386442
23.

Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute.

Rutz HP, Weber DC, Goitein G, Ares C, Bolsi A, Lomax AJ, Pedroni E, Coray A, Hug EB, Timmermann B.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):220-5. Epub 2008 Feb 20.

PMID:
18068310
24.

In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).

Albertini F, Lomax AJ, Hug EB.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1333-4; author reply 1334-5. No abstract available.

PMID:
17967323
25.

Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience.

Weber DC, Rutz HP, Bolsi A, Pedroni E, Coray A, Jermann M, Lomax AJ, Hug EB, Goitein G.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):865-71. Epub 2007 Jul 2.

PMID:
17606333
26.

Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature.

Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH.

J Neurooncol. 2007 Aug;84(1):49-55. Epub 2007 Mar 22. Review.

PMID:
17377740
27.
28.

Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13.

Elliott EA, Wright JR, Swann RS, Nguyen-Tân F, Takita C, Bucci MK, Garden AS, Kim H, Hug EB, Ryu J, Greenberg M, Saxton JP, Ang K, Berk L; Radiation Therapy Oncology Group Trial 99-13.

J Clin Oncol. 2006 May 1;24(13):2092-7.

PMID:
16648511
29.

Acquired Chiari malformation type I following fractionated radiation therapy to the anterior skull base in a 20-month-old boy. Case report.

Lollis SS, Hug EB, Gladstone DJ, Chaffee S, Duhaime AC.

J Neurosurg. 2006 Feb;104(2 Suppl):133-7.

PMID:
16506501
30.

Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.

Hein PA, Gladstone DJ, Bellerive MR, Hug EB.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1540-8.

PMID:
16029816
31.

Protons versus photons: a status assessment at the beginning of the 21st Century.

Hug EB.

Radiother Oncol. 2004 Dec;73 Suppl 2:S35-7.

PMID:
15971306
32.

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, Hug EB, Asbell SO, Grignon D.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1285-90.

PMID:
15817329
33.

Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements.

Krengli M, Hug EB, Adams JA, Smith AR, Tarbell NJ, Munzenrider JE.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):583-93.

PMID:
15667981
34.

Radiotherapy for local control of osteosarcoma.

DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE, Suit HD.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):492-8.

PMID:
15667972
35.

Radiation-induced cardiomyopathy as a function of radiation beam gating to the cardiac cycle.

Gladstone DJ, Flanagan MF, Southworth JB, Hadley V, Thibualt MW, Hug EB, Hoopes PJ.

Phys Med Biol. 2004 Apr 21;49(8):1475-84.

PMID:
15152686
36.
37.

[Diffusion-weighted MRI--a new parameter for advanced rectal carcinoma?].

Hein PA, Kremser C, Judmaier W, Griebel J, Rudisch A, Pfeiffer KP, Hug EB, Lukas P, DeVries AF.

Rofo. 2003 Mar;175(3):381-6. German.

PMID:
12635015
38.

Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study.

Hein PA, Kremser C, Judmaier W, Griebel J, Pfeiffer KP, Kreczy A, Hug EB, Lukas P, DeVries AF.

Eur J Radiol. 2003 Mar;45(3):214-22.

PMID:
12595106
39.

3-D-conformal radiation therapy for pediatric giant cell tumors of the skull base.

Hug EB, Muenter MW, Adams JA, de Vries A, Rosenberg AE, Munzenrider JE.

Strahlenther Onkol. 2002 May;178(5):239-44.

PMID:
12082682
40.

Conformal proton radiation therapy for pediatric low-grade astrocytomas.

Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, Grove RI, Slater JD.

Strahlenther Onkol. 2002 Jan;178(1):10-7.

PMID:
11977386
41.

Proton radiotherapy in management of pediatric base of skull tumors.

Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1017-24.

PMID:
11958897
42.

Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique.

Hug EB, Nevinny-Stickel M, Fuss M, Miller DW, Schaefer RA, Slater JD.

Med Pediatr Oncol. 2001 Jul;37(1):36-41.

PMID:
11466721
43.
44.

Full Scale IQ (FSIQ) changes in children treated with whole brain and partial brain irradiation. A review and analysis.

Fuss M, Poljanc K, Hug EB.

Strahlenther Onkol. 2000 Dec;176(12):573-81. Review.

PMID:
11140152
45.

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.

Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R.

J Neurooncol. 2000 Jun;48(2):151-60.

PMID:
11083080
46.

Proton radiation therapy for chordomas and chondrosarcomas of the skull base.

Hug EB, Slater JD.

Neurosurg Clin N Am. 2000 Oct;11(4):627-38. Review.

PMID:
11082173
47.

Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures.

Lin R, Hug EB, Schaefer RA, Miller DW, Slater JM, Slater JD.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1219-26.

PMID:
11072181
48.

Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique.

Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):979-84.

PMID:
10863068
49.

Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.

Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):927-33.

PMID:
10705015
50.

Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.

Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, Slater JD.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1117-26.

PMID:
10613303

Supplemental Content

Support Center